Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025)

Lantheus Holdings' (LNTH) quarterly Liabilities from Discontinued Operations came in at 22468000.0 in Q4 2025, down 21.35% on a QoQ basis from 28566000.0 in Q3 2025.

Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025) Analysis & Trends

Lantheus Holdings (LNTH) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 22468000.0 in Q4 2025.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 22468000.0 in Q4 2025; TTM through Dec 2025 was 22468000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 22468000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations for Q4 2025 stood at 22468000.0, down from 28566000.0 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for LNTH reached as high as 29845000.0 in Q2 2025 and fell as low as 22468000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 22.47 Mn
Dec 31, 2025 22.47 Mn
Sep 30, 2025 28.57 Mn
Sep 30, 2025 28.57 Mn
Jun 30, 2025 29.85 Mn
Jun 30, 2025 29.85 Mn
Dec 31, 2020 1.79 Mn
Dec 31, 2020 1.79 Mn
Dec 31, 2015 1.72 Mn
Dec 31, 2015 1.72 Mn